Melanotan (One) “afamelanotide” NBC News Report, November 1991

Melanotan (one) “afamelanotide” NBC News report, November 1991 – Melanotan (one) “afamelanotide” discovery by researchers at the University of Arizona in Tucson as explained by NBC News’ Robert Bazell (with Tom Brokaw introduction) in a November 1991 News report. Melanotan (one) is now being developed in Australia as a photoprotective medicine to treat people who’s skin is negatively affected (more than normal) by exposure to UV light. Clinuvel (originally named “Epitan”) is the company that has been working to develop it since 1999. They are currently conducting clinical trials (under the drug name “afamelanotide”). The expected release of Melanotan one on the market as a treatment option for Erythropoietic Protoporphyria (EPP) sufferers is likely to be either 2009 or 2010. Journal of the American Medical Association article that this report was based upon: jama.ama-assn.org www.clinuvel.com en.wikipedia.org melanotan.org afamelanotide

Merck: Current Investors Should Hold This Pharma Long-Term

Filed under: drug treatment news articles

The six new drugs are Odanacatib which treats osteoporosis, Suvorexant which treat insomnia, Sugammadex which treats adjudicated hypersensitivity, Vintafolide which treats various cancers, Tredaptive, a novel cholesterol medicine, and V503 which …
Read more on Seeking Alpha